Administration of nicotinamide mononucleotide suppresses the progression of age-related hearing loss in mice.

Kouya Hattori, Takashige Hamaguchi, Rika Azuma-Suzuki, Seiichiro Higashi, Aiko Manji, Masashi Morifuji

Wellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, 192-0919, Japan.Wellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, 192-0919, Japan. · pubmed

Paper

Abstract

Age-related hearing loss (ARHL) is a widespread problem in the elderly, significantly impairing their quality of life. Despite its high prevalence, no fundamental treatment for ARHL has been established. Nicotinamide adenine dinucleotide (NAD

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that the administration of nicotinamide mononucleotide can suppress the progression of age-related hearing loss in mice. This research addresses a specific aspect of aging by exploring a potential intervention that may mitigate a common age-related condition, thus contributing to the understanding of aging mechanisms.

Author of this paper? Send a correction.